$5.45
Last update: Aug 27, 4:00 PM
Market sentiment signals for Atea Pharmaceuticals (AVIR): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Outperform
2 analysts
Options Flow (P/C)
—
Avg Consensus PT
$9
+56.0%
Highest Price Target
$10
+83.5%
Lowest Price Target
$7
+28.4%
Short Interest
12.3%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Morgan Stanley | Matthew Harrison— | +28.4% | $6 → $7 | Maintained | Equal-Weight |
| Mar 9, 2026 | Evercore ISI Group | Jonathan Miller— | +83.5% | $6 → $10 | Maintained | Outperform |